ǰÑÔ
¼××´ÏÙ¹¦Ð§¼õÍËÖ¢(hypothyroidism)¼ò³Æ¼×¼õÖ¢£¬ÊÇÓÉÓÚÖÖÖÖÔµ¹ÊÔÓÉÒýÆð¼××´ÏÙ¼¤Ëغϡ¢ÉøÍ¸»ò¼××´ÏÙËØÉúÎïѧЧӦȱ·¦£¬µ¼Ö»úÌå´úлÔ˶¯ºÍ½»¸ÐÉñ¾ÐË·ÜÐÔϽµµÄÁÙ´²×ÛºÏÕ÷¡£Æä²¡ÀíÌØÕ÷ÊÇð¤¶àÌǵÈÔÚ×éÖ¯ºÍƤ·ôÖÐȺ¼¯£¬ÑÏÖØÕßÌåÏÖΪð¤ÒºÐÔË®Öס£Å®ÐԽ϶à¼û¡£±¬·¢ÔÚÌ¥¶ù»òÐÂÉú¶ùµÄ¼×¼õÖ¢³ÆÎª´ôС²¡£¨¿ËÍ¡²¡£©£¬ÌåÏÖΪÖÇÁ¦µÍϺͷ¢Óý»ºÂý¡£
ÒýÆð¼×¼õÖ¢µÄ²¡ÒòÖ÷ÒªÓУºÖÖÖÖ¼××´ÏÙÑ×Ôì³É¼××´ÏÙ×éÖ¯µÄËðÉËºÍÆÆËð£¬ÒýÆðÁ˼׼õÖ¢£»³¤Ê±¼äȱµâ£¬Ê¹ºÏ³É¼××´ÏÙ¼¤ËصÄÖÊÁÏȱ·¦£¬Òò¶ø¼××´ÏÙ¼¤ËصĺϳÉïÔÌ£»¼××´ÏÙÊÖÊõʱ£¬½«¼××´ÏÙËùÓÐÇгý£¬»òÇгýµÄ¼××´ÏÙ×éÖ¯¹ý¶à£¬Òà¿ÉÒýÆð¼×¼õÖ¢£»·ÅÉäÐÔ131µâÖÎÁÆÊ±£¬131µâÓÃÁ¿¹ý´ó£¬Ê¹¼××´ÏÙ×éÖ¯ÆÆËð¹ý¶à£¬Òà¿É·ºÆð¼×¼õÖ¢£»ÓÐЩҩÎï¿ÉÒÔÒÖÖÆ¼××´ÏÙ¼¤ËصÄÌìÉú£¬Òò¶øÒýÆð¼×¼õÖ¢£»ÏÂÇðÄÔ£´¹Ì岡±äʱ£¬Òò´Ù¼××´ÏÙ¼¤ËØÈ±·¦£¬Ê¹¼××´ÏÙÌìÉú¼××´ÏÙ¼¤ËصĹ¦Ð§¼õµÍ¡£
Õë¶ÔÉÏÊö²¡Òò£¬¼×¼õÖ¢µÄ¶¯ÎïÄ£×ÓÓÐÓÕ·¢ÐÔ¶¯ÎïÄ£×Ó¡¢×Ô¾õÐÔ¶¯ÎïÄ£×ӺͻùÒòÐÞÊζ¯ÎïÄ£×Ó3Àà¡£
²¿·ÖÔìÄ£ÒªÁì
ʹÓö¯ÎСÊó
¡¾ÔìÄ£»úÖÆ¡¿£º
¼××´ÏÙÌØÒìÐÔת¼Òò×Ó1(thyroid-specific transcription factor 1,TTF-1)ÓֳƼ××´ÏÙÌØÒìÐÔÔöÇ¿×ÓÍŽáÂѰ×(thyroid-specific enhancer-binding protein)£¬ÊÇת¼Òò×Ó¼Ò×åµÄÒ»¸ö³ÉÔ±£¬º¬ÓÐͬԴ¿òÓò¡£TTF-1ÔÚÅßÌ¥Æ÷¹ÙÐγÉÖм«ÆäÖ÷Òª£¬TTF-1»ùÒòÇóý½«µ¼ÖÂËÀÌ¥£¬È±·¦¼××´Ïٺʹ¹ÌåÏÙ£¬·ÎºÍǰÄÔ¸¹²à¡¢»ù²¿È±ÏÝ£¬ÒÔ¼°²Ò°×Çò½á¹¹·¢Óý²»È«¡£
TTF-1»ùÒò±í´ï¼××´ÏÙ¹ýÑõ»¯Îïø¡¢¼××´ÏÙÇòÂѰ׺ʹټ××´ÏÙ¼¤ËØÊÜÌå3ÖÖÂѰס£ÕâÈýÖÖÂѰ׶Լ××´ÏÙËØµÄÉúÎïºÏ³ÉÖÁ¹ØÖ÷Òª¡£TTF-1»ùÒòÇóýµ¼ÖÂÏÈÌìÐÔ¼×¼õÖ¢¡£
¡¾ÔìÄ£ÒªÁì¡¿£º
º¬ÓÐTTF-1»ùÒòµÄÕû¸ö±àÂëÇøºÍ3’¶Ë·Ç±àÂëÇøÐòÁй²5.9kbÓÃÀ´¹¹½¨´ò°ÐÔØÌ壬Õýɸѡneor»ùÒò²åÈëµ½TTF-1»ùÒòµÄµÚ2ÍâÏÔ×ÓÖÐÐÄ£¬µ¼ÖÂͬԴÓòÐòÁеĵÚ1¸öÂÝÐýÆÆËð£»tk±í´ïºÐÓÃÓÚ·ÇÍ¬Ô´ÖØ×éµÄ¸ºÉ¸Ñ¡¡£É¸Ñ¡³öµÄ¶¨µãÕûºÏESϸ°û¿Ë¡ÏÔ΢עÉäµ½C57BL/6СÊóÅßÄÚ£¬±¬·¢Ç¶ºÏÌåСÊó¡£5/9µÄÐÛÐÔǶºÏÌåСÊó½«ESϸ°û»ùÒò×é´«¸øÁË×ÓÅ®¡£
¡¾Ä£×ÓÌØµã¡¿£º
ÔÓºÏ×ÓСÊó·¢ÓýÕý³£¡£´¿ºÏ×ÓСÊó³öÉúʱ¼´éæÃü£¬ÎÞ¼××´ÏÙ£¬µ«ÓÐÕý³£µÄ¼××´ÅÔÏÙ£¬È±·¦·ÎʵÖÊ£¬µ«¾ßÓлù±¾µÄÖ§Æø¹ÜÊ÷£¬ÐØÄ¤Ç»ÉÏÆ¤Òì³££¬´¿ºÏ×ÓСÊóÄÔÄÚÆÕ±éȱÏÝ£¬ÌØÊâÊÇǰÄԵĸ¹²¿¡£Õû¸ö´¹Ì壨°üÀ¨Ç°Ò¶¡¢ÖÐÒ¶ºÍºóÒ¶£©È±·¦¡£ÔλÔÓ½»ÏÔʾTTF-1»ùÒòÔÚÅßÌ¥±¬·¢ÔçÆÚÔÚÕý³£¼××´ÏÙ¡¢·ÎÖ§Æø¹ÜÉÏÆ¤ºÍǰÄÔµÄÌØÒìÐÔÇøÓò±í´ï¡£
¡¾Ä£×ӵįÀ¹ÀºÍÓ¦Óá¿£º
´ËÄ£×Ó¿ÉÓÃÓÚÏÈÌìÐÔ¼×¼õ֢̥×з¢ÓýµÄÑо¿¡£ÓÉÓÚTTF-1ÔÚÅßÌ¥¶àÖÖÆ÷¹ÙÐγÉÖÐÆð×÷Óã¬TTF-1»ùÒòÇóý²»µ«Ó°Ïì¼××´ÏÙËØµÄºÏ³É£¬Ò²Ó°ÏìÆäËûÆ÷¹Ù£¨ÈçÄÔ¡¢´¹Ìå¡¢·ÎÔàµÈ£©µÄÐγɣ¬²¢²»ÍêÈ«ÇкÏÏÈÌìÐÔ¼×¼õÖ¢µÄÁÙ´²ÌåÏÖ£¬ÓôËÄ£×ÓÔÚÆÊÎöʵÑéЧ¹ûʱӦ¼ÓÒÔ×¢ÖØ¡£
²Î¿¼ÎÄÏ×£º
1.ÀîÀö£¬Àîºì壬ËÎÑÒ£¬µÈ£®¶ÌÆÚµâÌúÍŽáȱ·¦´óÊó¶¯ÎïÄ£×ӵĽ¨É裮ÇéÐÎÓ뿵½¡ÔÓÖ¾£¬2010, 27 (7):565-567
2.Mansouri A, Chowdhury K, Gruss P. Follicular cells of the thyroid g.land require Pax8 gene function. Nat Genet, 1998, 19(1):87-90
3.Amendola E, De Luca P, Macchia PE, et al. A mouse model demonstrates a multigenic origin of congenital hypothyroidism. Endocrinology, 2005, 146 (12): 5038- 5047
4.Hetzel BS, Mano MT. A review of e.xperimental studies of iodine deficiency during fetal development. J Nutr, 1989, 119(2): 145-151
5.Eftekhari MH,Keshavarz SA,Jalali M,et al. The relationship between iron status and thyroid hormone concentration in iron-deficient adolescent Iranian girl . Asia Pac J Clin Nutr, 2006, 15 (1):50-55
6.Argumedo GS,Sanz CR,Olgu í n HJ. Experimental models of developmental hypothyroidism. Horm Metab Res,2012,44 (2):79-85
7.Johnson KR,Marden CC, Ward-Bailey P,et al. Congenital hypothyroidism,dwarfism, and hearing impairment caused by a missense mutation in the mouse dual oxidase 2 gene, Duox2. Mol Endocrinol, 2007, 21 (7):1593-1602
8.Kimura S, Hara Y, Pineau T, el al. The T/ebp null mouse: thyrojd-specific enhancer-binding protein is essential for the organogenesis of the thyroid, lung, ventral forebrain, and pituitary. Genes Dev, 1996, 10(1):60-69
9.Usenko V, Lepekbin E,Lyzoguhov V,el al. The influence of low doses 131 I-induced maternal hypothyroidism on the development of rat embryos. Exp Toxicol Patbol, 1999, 51 (3):223-227